Ernst Timothy S's Form 4 filing
Bio-Rad Laboratories, Inc. (BIO) · filed Mar 8, 2023
- Accession no.
- 0001062993-23-006320
- Filed
- Mar 8, 2023
- Trade date
- Mar 8, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $849.3K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ernst Timothy SCIK 0001676291 | Officer (EVP, General Counsel & Sec) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | Bio-Rad A Common Stock | MOption exerciseAcquired | +850 | $159.32 | +$135,422 | 4,267.36 | Direct | |
| Mar 8, 2023 | Bio-Rad A Common Stock | MOption exerciseAcquired | +150 | $215.98 | +$32,397 | 4,417.36 | Direct | |
| Mar 8, 2023 | Bio-Rad A Common Stock | SSaleDisposed | −1,000 | $486.08 | −$486,080 | 3,417.36 | Direct | |
| Mar 8, 2023 | Bio-Rad A Common Stock | SSaleDisposed | −746 | $486.89 | −$363,219.94 | 2,671.36 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | Bio-Rad A Common Stock | MOption exerciseDisposed | −850 | $0.00 | $0 | 0 | Direct | |
| Mar 8, 2023 | Bio-Rad A Common Stock | MOption exerciseDisposed | −150 | $0.00 | $0 | 2,350 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.